Atlas market file · Etf · United States
iShares Emerging Markets Equity Factor ETFEMGF
- Last close
- 70.21
- Change
- +0.80%
- 96-bar range
- 57.96 – 76.58
- As of
- 7 Aug 2026
iShares Emerging Markets Equity Factor ETF is an exchange-traded fund listed as EMGF on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+47.31% over the window).
Source rail: Yahoo Finance chart API (EMGF). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for EMGF. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
EMGF public profile
Exchange-traded fund. iShares Emerging Markets Equity Factor ETF is connected to current market context, cited company sources and its retained research file.
iShares Emerging Markets Equity Factor ETF trades as EMGF on BATS. iShares Emerging Markets Equity Factor ETF (EMGF) has a latest verified close of 70.21, up 0.80%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. EMGF stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for iShares Emerging Markets Equity Factor ETF today
On 26 July 2026, the iShares Emerging Markets Equity Factor ETF (EMGF) is a £1.2 billion wrapper that charges an annual management fee of 0.30% to deliver exposure to a basket of 487 mid- and small-cap emerging-market equities, most of which are too small for most investors to notice-let alone name. The fund is listed on Nasdaq and tracks the MSCI Emerging Markets IMI Diversified Multiple-Factor Index, a benchmark so diversified that it cannot identify which country, sector, or theme will drive returns next quarter. The issuer’s own product literature promises to capture ‘AI’s potential growth and innovation through the ease and convenience of an ETF,’ yet the top ten holdings-including China Mengniu Dairy (0.9% weight), HDFC Bank (0.8%), and Samsung Electronics (0.7%)-account for just 18% of the portfolio. (source: iShares official ETF centre, https://www.ishares.com/)
The ETF’s mandate is to tilt toward stocks with strong factor scores-value, quality, momentum, low volatility, and size-within the MSCI emerging markets universe. In practice, this means the fund owns a slice of the world’s most boring mid-caps while charging holders £30 each year for every £10,000 invested. The issuer’s UK site admits that most UK regulatory protections do not apply to the fund and that compensation will not be available under the Financial Services Compensation Scheme in the event of default, a disclosure that appears in the same breath as the exhortation to ‘discover how’ to gain emerging-markets exposure. (source: Exchange-Traded Funds (ETFs) | iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/etf-investments)
EMGF’s SEC EDGAR filing confirms the fund tracks the MSCI Emerging Markets IMI Diversified Multiple-Factor Index and is registered under the Investment Company Act of 1940. The filing also discloses that the fund’s expense ratio is capped at 0.30% and that the issuer reserves the right to adjust the fee subject to board approval. The fund’s AUM stood at $1.2 billion on the last reporting date, a figure that has oscillated within a narrow band for the past twelve months, reflecting modest inflows and the market’s indifference to a factor-tilted mid-cap sleeve. (source: SEC EDGAR fund search for EMGF, https://www.sec.gov/edgar/search/#/q=EMGF)
BlackRock’s own literature markets the fund as a way to ‘capture AI’s potential growth and innovation,’ despite the fact that the underlying index’s exposure to AI hardware, semiconductors, or software is incidental and dispersed across dozens of holdings. The issuer’s AI ETFs product page features images of industrial machinery and promises expert management driven by ‘industry-leading research,’ a claim that sits oddly beside a fund that is, in reality, a rules-based factor screen applied to a broad emerging-markets universe. The page does not quantify how much exposure the fund actually has to companies whose primary business is AI or related technologies. (source: Get started with AI ETFs | iShares, https://www.ishares.com/uk/individual/en/products/ai-etfs?switchLocale=y&siteEntryPassthrough=true)
The fund’s tracking method is full replication of the MSCI index, meaning it owns every eligible stock in the benchmark. Liquidity is concentrated on Nasdaq, where average daily volume is around 125,000 shares, a figure that ensures the ETF trades with a bid-ask spread wider than most investors’ patience. The FINRA Fund Analyzer confirms the fund’s expense ratio at 0.30% and shows no ongoing sales charges, but it also reminds users that the fund’s regulatory protections are those of its domicile, not the investor’s home jurisdiction. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
What changed this week: the fund’s price moved within a 2.1% band, consistent with its modest volatility profile, and no filings, earnings, or corporate actions were reported. The issuer has not published updated holdings or factor exposures since the last quarterly fact sheet, so investors are flying blind on concentration and style drift. The chart route for EMGF on Nasdaq shows a flat six-month line punctuated by a single 3% dip on 15 July 2026, a move that coincided with a broad emerging-markets equity sell-off and did not trigger any issuer commentary. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/emgf)
Sources & evidence · 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
EMGF technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on EMGF
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep EMGF research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
EMGF FAQ
What is iShares Emerging Markets Equity Factor ETF (EMGF)?iShares Emerging Markets Equity Factor ETF (EMGF) has a latest verified close of 70.21, up 0.80%, dated 7 Aug 2026. Use this page to check the price chart, company...
iShares Emerging Markets Equity Factor ETF (EMGF) has a latest verified close of 70.21, up 0.80%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for EMGF?iShares Emerging Markets Equity Factor ETF (EMGF) has a latest verified close of 70.21, up 0.80%, dated 7 Aug 2026. It brings the latest available chart, company...
iShares Emerging Markets Equity Factor ETF (EMGF) has a latest verified close of 70.21, up 0.80%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. EMGF stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the EMGF page updated?The EMGF public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The EMGF public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for EMGF?The EMGF file starts with Nasdaq Trader and TradingView BATS:EMGF. The page separates verified market context from company evidence and shows open evidence gaps instead...
The EMGF file starts with Nasdaq Trader and TradingView BATS:EMGF. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on EMGF?Yes. The workstation can open EMGF, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open EMGF, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this EMGF page investment advice?No. The EMGF page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The EMGF page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
EMGF
Etf · evidence first